Pfizer

Athenry’s 1,000-job bonanza comes against ongoing concern about the carrying capacity of the Irish economy

US medical device company says facility will create 1,000 jobs in region

Group says it remains on track to achieve its 7%-9% revenue growth from other products this year

European health officials have advocated portfolio diversity to help fight different variants

More than 850,000 doses of past-expiry date Covid-19 vaccines thrown out

As the end of the pandemic brings Pfizer to a year of transition, its country manager for Ireland says the group’s drug pipeline is the strongest it’s ever been

Multinational chief executives stress the importance of creating a more level playing field if China wants to attract more foreign investment

Trade union Unite says it is considering appeal of High Court decision

EU ethics controversies ‘play into the hands of Eurosceptics and anti-vaxxers’, says European Ombudsman

US pharma group plans to pay $229 in cash per share as it aims to ‘advance the battle against cancer’

Novavax had a terrible week while Pfizer and Moderna are well off their pandemic highs

Questions remain about hospitalisation and side effects but drugmaker stays step ahead of British group GSK which faces similar panel

Manufacturing woes meant it lost out in race to market with its Covid vaccine

Pharma group is launching 19 drugs over the next 18 months to counteract a sharp fall in sales from pandemic highs

Vaccination recommended for young children with underlying health conditions

Roles will mostly be in the professional services and outsourcing leader's life sciences manufacturing division

Ireland has moved from a position when a lot of factors were in its favour to a more mixed picture

Results may allow pharma giant to compete with treatment approved in US last month

Appointment follows Laurence Flavin's decision to leave medical device company

Agency’s figures also point to partial displacement of trade following UK’s exit from EU

While scientists performed their magic, engineer Mike McDermott was charged with managing a fifteen-fold increase in the group’s vaccine manufacturing capacity

Business Today: the best news, analysis and comment from The Irish Times business desk

New facility to be built on Grange Castle site, adding 400-500 jobs

Sales drop 43% in third quarter as primary immunisation drives reach completion

In a staggering level of exposure 10 per cent of all tax revenue in Ireland is now coming from just 10 American corporations

US drug giant raises forecast for annual sales of its Covid-19 vaccine by $2bn on back of demand for Omicron boosters and plans for price rises

Capability to work with mRNA technology puts Dublin site in line for major additional investment

Seen & heard: Aer Lingus workers seek pay hike; Pfizer plans €1bn Dublin factory; Mike Ashley swoops on Asos

Pfizer, Apple and Amazon also feature high on the rankings

Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic

Top jab makers lose combined $10bn of market value amid fears over growing public apathy

Incoming Ipha president says industry expects to bring 30 new medicines to market in Ireland next year but warns on patent protection

Vaccines also include original version of virus

US biotech claims rival Covid vaccine makers infringed patents underpinning jabs

Just 647 Irish patients have used Paxlovid, taken by US president Joe Biden when he caught the virus last month

Antiviral treatment Paxlovid is being widely prescribed despite questions about its effectiveness

Pfizer encourages its people to think big and the results are visible in its ESG Strategy and innovative sustainability projects

US pharma group to pay €90.5m for 8% in deal that will boost joint Lyme disease programme

Shares rise sharply, surging by 14.5% in early session trading

President hails ‘monumental step forward’ in battle against virus but parents have been more cautious in inoculating children